Docetaxel-induced alopecia can be prevented-Reference-Cited by-同舟云学术

Docetaxel-induced alopecia can be prevented

Published:1995-08 Issue:8971 Volume:346 Page:371-372
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lemenager M.,Genouville C.,Bessa E.H.,Bonneterre J.

Publisher

Elsevier BV

Subject

General Medicine

Reference3 articles.

1. First line chemotherapy with docetaxel in advanced breast cancer (ABC): a phase II study of EORTC Clinical Screening Group (CSG);Fumoleau;J Clin Oncol,1993

2. Second EORTC Clinical Screening Group phase II trial of docetaxel as first line chemotherapy in advanced breast cancer;Dieras;J Clin Oncol,1994

3. Evaluation of two doses of docetaxel as first line chemotherapy in advanced breast cancer: report of the EORTC Clinical Screening Group;Fumoleau,1994

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of the DigniCap System in preventing chemotherapy‐induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device;International Journal of Nursing Practice;2020-09-22

2. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy;Supportive Care in Cancer;2020-05-09

3. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy;Clinical Breast Cancer;2015-10

4. Antimicrotubule Agents;Dermatologic Principles and Practice in Oncology;2013-11-30

5. Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations;Expert Review of Dermatology;2011-02